Japanese Patients Treated in the IMPERIAL Randomized Trial Comparing Eluvia and Zilver PTX Stents

ConclusionThe results show excellent vessel patency and a good safety profile up to 1  year in the subgroup of Japanese patients in IMPERIAL treated with Eluvia for femoropopliteal artery disease.Level of EvidenceLevel 3; subgroup analysis of randomized trial.Clinical Trial RegistrationClinicalTrials.gov, identifier NCT02574481.
Source: CardioVascular and Interventional Radiology - Category: Radiology Source Type: research